의료 폐기물 관리 시장 규모, 점유율 및 동향 분석 보고서 : 처리 시설별, 처리 방법별, 지역별 및 부문별 전망(2026-2033년)

The global medical waste management market was valued at USD 41.3 billion in 2025 and is projected to grow from USD 44.6 billion in 2026 to USD 76.4 billion in 2033, at a CAGR of 8.0% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 31.0% in 2025. The market growth is primarily driven by the continuous expansion of healthcare infrastructure, increasing hospital admissions, surgical procedures, diagnostic testing, and pharmaceutical activities, all of which generate larger volumes of regulated medical waste. Additionally, ongoing advancements in medical technologies and healthcare services are driving the adoption of advanced diagnostic, surgical, and treatment solutions, further increasing the need for efficient medical waste management.

In addition, the growing incidence of diseases like cancer and other chronic disorders, along with an increasing elderly population and road accidents, is leading to a heightened demand for these advanced medical solutions. Consequently, the widespread availability of advanced medical solutions, combined with a growing patient population, is resulting in a significant volume of waste and byproducts.

The pharmaceutical industry is experiencing swift progress in the adoption of innovative manufacturing techniques for drugs and medical devices. In addition, the market's expansion is evident in the effective supply chain management of inventory, which is crucial to the daily operations of hospitals, clinics, and diagnostic centers. Consequently, this heightened activity contributes to increased generation of medical waste. To manage these by-products and residues, there is a growing need for a systematic and efficient service that encompasses the collection, transportation, disposal, and recycling of specific materials as needed.

Certain treatment, disposal, and recycling processes emit harmful gases and compounds, including mercury and oxides. According to the World Health Organization, healthcare activities generate significant volumes of waste globally, with about 85% classified as non-hazardous and around 15% considered hazardous, requiring proper treatment and disposal through regulated systems to prevent health and environmental risk. These hazardous substances pose the risk of land, air, and water pollution, leading to the dissemination of infectious agents and potential cancer risks. The growth of the industry is consequently influenced by advancements in techniques for the treatment, disposal, and recycling of these materials.

In addition, supportive regulatory policies and increasing investments in hazardous and medical waste treatment infrastructure are expected to accelerate market growth by strengthening waste disposal capabilities and ensuring compliance with stringent environmental standards. For instance, in June 2025, Veolia announced the strategic expansion of its U.S. hazardous waste treatment business through three acquisitions and organic capacity enhancements. As part of this initiative, the company committed more than USD 350 million over three years to expand treatment infrastructure and enhance operational capabilities across North America. The expansion is expected to improve waste collection, treatment, and disposal capacity while enabling healthcare providers to manage the growing volumes of infectious and hazardous medical waste more efficiently. Such investments reflect the rising demand for integrated, compliant, and sustainable medical waste management solutions driven by expanding healthcare services and increasingly stringent waste disposal regulations.

Also, there is a rise in R&D investment and facility expansion by pharmaceutical and biotechnology firms to support the approval and launch of new drugs in the market. High R&D investments and adequate supply and logistics facilities are likely to increase the likelihood of a successful drug/medicine.

However, an anticipated significant transition in the market, moving from larger players to smaller local players, is expected to hinder growth. Developing countries allocate substantial capital for the adoption of advanced technologies aimed at mitigating pollution and other adverse effects on the ecosystem during the treatment and disposal processes. However, these nations lack clear and stringent guidelines and regulations for the management of medical waste, posing a hindrance to market growth.

Global Medical Waste Management Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the Medical Waste Management market report based on treatment sites, treatment, and region:

• Treatment Site Outlook (Revenue, USD Billion, 2021 - 2033)

Onsite

• Collection
• Treatment
• Recycling
• Others

Offsite

• Collection
• Treatment
• Recycling
• Others
• Treatment Outlook (Revenue, USD Billion, 2021 - 2033)

Incineration

Autoclaving

Chemical treatment

Others

• Regional Outlook (Revenue, USD Billion, 2021 - 2033)

North America

• U.S.
• Canada

Europe

• UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway

Asia Pacific

• Japan
• China
• India
• South Korea
• Australia
• Thailand

Latin America

• Brazil
• Mexico
• Argentina

Middle East & Africa

• South Africa
• Saudi Arabia
• UAE
• Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Segment Definitions
    • 1.1.1.1. Treatment Site Segment
    • 1.1.1.2. Treatment segment
• 1.2. Regional Scope
• 1.3. Estimates And Forecast Timeline
• 1.4. Objectives
  • 1.4.1. Objective - 1
  • 1.4.2. Objective - 2
• 1.5. Research Methodology
• 1.6. Information Procurement
  • 1.6.1. Purchased Database
  • 1.6.2. GVR's Internal Database
  • 1.6.3. Secondary Sources
  • 1.6.4. Primary Research
• 1.7. Information or Data Analysis
  • 1.7.1. Data Analysis Models
• 1.8. Market Formulation & Validation
• 1.9. Model Details
  • 1.9.1. Commodity Flow Analysis
• 1.10. List of Primary Sources
• 1.11. List of Abbreviations

Chapter 2. Medical Waste Management Market: Executive Summary

• 2.1. Market Snapshot
• 2.2. Treatment Site and Treatments Snapshots
• 2.3. Competitive Landscape Snapshot

Chapter 3. Medical Waste Management Market Variables, Trends, & Scope

• 3.1. Market Segmentation and Scope
• 3.2. Market Lineage Outlook
  • 3.2.1. Parent Market Outlook
  • 3.2.2. Related/Ancillary Market Outlook
• 3.3. Market Dynamics
• 3.4. Market Drivers Analysis
  • 3.4.1. Growing government initiatives
  • 3.4.2. Technological advancement leads to non-incineration techniques.
  • 3.4.3. Overall growing healthcare industry
• 3.5. Market Restraint Analysis
  • 3.5.1. Large companies face stiff competition from small-sized local vendors.
  • 3.5.2. Lack of stringent regulations for medical waste management in developing countries
• 3.6. Medical Waste Management Market Analysis Tools
  • 3.6.1. Industry Analysis - Porter's
    • 3.6.1.1. Supplier Power
    • 3.6.1.2. Buyer Power
    • 3.6.1.3. Substitution Threat
    • 3.6.1.4. Threat of New Entrant
    • 3.6.1.5. Competitive Rivalry
  • 3.6.2. PESTLE Analysis
    • 3.6.2.1. Political Landscape
    • 3.6.2.2. Technological Landscape
    • 3.6.2.3. Economic Landscape
  • 3.6.3. Pricing Analysis

Chapter 4. Medical Waste Management: Treatment Site Estimates & Trend Analysis

• 4.1. Treatment Site Market Share, 2025 & 2033
• 4.2. Segment Dashboard
• 4.3. Global Medical Waste Management Market by Treatment Site Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 For the Following
  • 4.4.1. On site
    • 4.4.1.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
      • 4.4.1.1.1. Collection
        • 4.4.1.1.1.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
      • 4.4.1.1.2. Treatment
        • 4.4.1.1.2.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
      • 4.4.1.1.3. Recycling
        • 4.4.1.1.3.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
      • 4.4.1.1.4. Others
        • 4.4.1.1.4.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 4.4.2. Off site
    • 4.4.2.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
      • 4.4.2.1.1. Collection
        • 4.4.2.1.1.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
      • 4.4.2.1.2. Treatment
        • 4.4.2.1.2.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
      • 4.4.2.1.3. Recycling
        • 4.4.2.1.3.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
      • 4.4.2.1.4. Others
        • 4.4.2.1.4.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)

Chapter 5. Medical Waste Management: Treatment Estimates & Trend Analysis

• 5.1. Treatment Market Share, 2025 & 2033
• 5.2. Segment Dashboard
• 5.3. Global Medical Waste Management Market by Treatment Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 For the Following
  • 5.4.1. Incineration
    • 5.4.1.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 5.4.2. Autoclaving
    • 5.4.2.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 5.4.3. Chemical treatment
    • 5.4.3.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 5.4.4. Others
    • 5.4.4.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)

Chapter 6. Regional Business Analysis

• 6.1. Regional Market Share Analysis, 2025 & 2033
• 6.2. Regional Market Dashboard
• 6.3. Global Regional Market Snapshot
• 6.4. Marker Size, & Forecasts Trend Analysis, 2021 to 2033:
• 6.5. North America
  • 6.5.1. U.S.
    • 6.5.1.1. Key Country Dynamics
    • 6.5.1.2. Competitive Scenario
    • 6.5.1.3. Regulatory Framework
    • 6.5.1.4. U.S. Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 6.5.2. Canada
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Competitive Scenario
    • 6.5.2.3. Regulatory Framework
    • 6.5.2.4. Canada Market Estimates and Forecasts 2021 to 2033 (USD Million)
• 6.6. Europe
  • 6.6.1. UK
    • 6.6.1.1. Key Country Dynamics
    • 6.6.1.2. Competitive Scenario
    • 6.6.1.3. Regulatory Framework
    • 6.6.1.4. UK Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 6.6.2. Germany
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Competitive Scenario
    • 6.6.2.3. Regulatory Framework
    • 6.6.2.4. Germany Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 6.6.3. Spain
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Competitive Scenario
    • 6.6.3.3. Regulatory Framework
    • 6.6.3.4. Spain Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 6.6.4. France
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Competitive Scenario
    • 6.6.4.3. Regulatory Framework
    • 6.6.4.4. France Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 6.6.5. Italy
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Competitive Scenario
    • 6.6.5.3. Regulatory Framework
    • 6.6.5.4. Italy Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 6.6.6. Denmark
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Competitive Scenario
    • 6.6.6.3. Regulatory Framework
    • 6.6.6.4. Denmark Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 6.6.7. Sweden
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Competitive Scenario
    • 6.6.7.3. Regulatory Framework
    • 6.6.7.4. Sweden Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 6.6.8. Norway
    • 6.6.8.1. Key Country Dynamics
    • 6.6.8.2. Competitive Scenario
    • 6.6.8.3. Regulatory Framework
    • 6.6.8.4. Norway Market Estimates and Forecasts 2021 to 2033 (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Japan
    • 6.7.1.1. Key Country Dynamics
    • 6.7.1.2. Competitive Scenario
    • 6.7.1.3. Regulatory Framework
    • 6.7.1.4. Japan Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 6.7.2. China
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Competitive Scenario
    • 6.7.2.3. Regulatory Framework
    • 6.7.2.4. China Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 6.7.3. India
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Competitive Scenario
    • 6.7.3.3. Regulatory Framework
    • 6.7.3.4. India Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 6.7.4. South Korea
    • 6.7.4.1. Key Country Dynamics
    • 6.7.4.2. Competitive Scenario
    • 6.7.4.3. Regulatory Framework
    • 6.7.4.4. South Korea Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 6.7.5. Thailand
    • 6.7.5.1. Key Country Dynamics
    • 6.7.5.2. Competitive Scenario
    • 6.7.5.3. Regulatory Framework
    • 6.7.5.4. Thailand Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 6.7.6. Australia
    • 6.7.6.1. Key Country Dynamics
    • 6.7.6.2. Competitive Scenario
    • 6.7.6.3. Regulatory Framework
    • 6.7.6.4. Australia Market Estimates and Forecasts 2021 to 2033 (USD Million)
• 6.8. Latin America
  • 6.8.1. Brazil
    • 6.8.1.1. Key Country Dynamics
    • 6.8.1.2. Competitive Scenario
    • 6.8.1.3. Regulatory Framework
    • 6.8.1.4. Brazil Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 6.8.2. Mexico
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Competitive Scenario
    • 6.8.2.3. Regulatory Framework
    • 6.8.2.4. Mexico Medical Waste Management Market, 2018 - 2030 (USD Million)
  • 6.8.3. Argentina
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Competitive Scenario
    • 6.8.3.3. Regulatory Framework
    • 6.8.3.4. Argentina Market Estimates and Forecasts 2021 to 2033 (USD Million)
• 6.9. MEA
  • 6.9.1. MEA Medical Waste Management Market, 2018-2030 (USD Million)
  • 6.9.2. South Africa
    • 6.9.2.1. Key Country Dynamics
    • 6.9.2.2. Competitive Scenario
    • 6.9.2.3. Regulatory Framework
    • 6.9.2.4. South Africa Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 6.9.3. Saudi Arabia
    • 6.9.3.1. Key Country Dynamics
    • 6.9.3.2. Competitive Scenario
    • 6.9.3.3. Regulatory Framework
    • 6.9.3.4. Saudi Arabia Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 6.9.4. UAE
    • 6.9.4.1. Key Country Dynamics
    • 6.9.4.2. Competitive Scenario
    • 6.9.4.3. Regulatory Framework
    • 6.9.4.4. UAE Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 6.9.5. Kuwait
    • 6.9.5.1. Key Country Dynamics
    • 6.9.5.2. Competitive Scenario
    • 6.9.5.3. Regulatory Framework
    • 6.9.5.4. Kuwait Market Estimates and Forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company /Competition Categorization
• 7.3. Vendor Landscape
  • 7.3.1. List of Key Distributors and Channel Partners
  • 7.3.2. Key Customers
  • 7.3.3. Key Company Market Share Analysis, 2023
  • 7.3.4. REMONDIS SE & CO. KG
    • 7.3.4.1. Overview
    • 7.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.3.4.3. Product Benchmarking
    • 7.3.4.4. Strategic Initiatives
  • 7.3.5. Republic Treatment Sites, Inc
    • 7.3.5.1. Overview
    • 7.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.3.5.3. Product Benchmarking
    • 7.3.5.4. Strategic Initiatives
  • 7.3.6. Sharp Compliance, Inc.
    • 7.3.6.1. Overview
    • 7.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.3.6.3. Product Benchmarking
    • 7.3.6.4. Strategic Initiatives
  • 7.3.7. Stericycle, Inc
    • 7.3.7.1. Overview
    • 7.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.3.7.3. Product Benchmarking
    • 7.3.7.4. Strategic Initiatives
  • 7.3.8. SUEZ ENVIRONNEMENT
    • 7.3.8.1. Overview
    • 7.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.3.8.3. Product Benchmarking
    • 7.3.8.4. Strategic Initiatives
  • 7.3.9. Veolia
    • 7.3.9.1. Overview
    • 7.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.3.9.3. Product Benchmarking
    • 7.3.9.4. Strategic Initiatives
  • 7.3.10. WASTE MANAGEMENT, INC.
    • 7.3.10.1. Overview
    • 7.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.3.10.3. Product Benchmarking
    • 7.3.10.4. Strategic Initiatives
  • 7.3.11. CLEAN HARBORS, INC.
    • 7.3.11.1. Overview
    • 7.3.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.3.11.3. Product Benchmarking
    • 7.3.11.4. Strategic Initiatives
  • 7.3.12. BIOMEDICAL WASTE SOLUTIONS, LLC
    • 7.3.12.1. Overview
    • 7.3.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.3.12.3. Product Benchmarking
    • 7.3.12.4. Strategic Initiatives
  • 7.3.13. DANIELS SHARPSMART, INC.
    • 7.3.13.1. Overview
    • 7.3.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.3.13.3. Product Benchmarking
    • 7.3.13.4. Strategic Initiatives